3.8 Article

Guidelines on optimizing the use of proton pump inhibitors: PPI stewardship

Related references

Note: Only part of the references are listed.
Article Infectious Diseases

Management of Helicobacter pylori infection in paediatric patients in Europe: results from the EuroPedHp Registry

Thu Giang Le Thi et al.

Summary: The EuroPedHp-registry aims to monitor the management, antibiotic resistance, and eradication success of tailored triple therapy for Helicobacter pylori-infected children. The study found that guideline-conform 2-week therapy achieved primary eradication of >= 90%, but higher failure rates were observed in single-resistant strains.

INFECTION (2023)

Review Gastroenterology & Hepatology

Vitamin B12 deficiency and use of proton pump inhibitors: a systematic review and meta-analysis

Arup Choudhury et al.

Summary: This systematic review examines the impact of proton pump inhibitors (PPI) on the absorption of vitamin B12 and finds that PPI use may increase the risk of vitamin B12 deficiency. Although some studies suggest a slightly higher risk of vitamin B12 deficiency in PPI users, the pooled analysis results are not clear enough, and better-designed prospective studies are needed to further clarify this issue.

EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2023)

Review Pharmacology & Pharmacy

Proton Pump Inhibitors' Use and Risk of Iron Deficiency Anaemia: A Systematic Review and Meta-analysis

Mohammad Daud Ali

Summary: Recent systematic review and meta-analysis have found a significant association between the use of proton-pump inhibitors and an increased risk of iron death anaemia (IDA). Therefore, prescriber physicians should exercise caution when prescribing PPIs to individuals taking it for a long time and ensure that their serum iron levels are checked to avoid the risk of IDA.

CURRENT REVIEWS IN CLINICAL AND EXPERIMENTAL PHARMACOLOGY (2023)

Article Gastroenterology & Hepatology

ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease

Philip O. Katz et al.

Summary: This article provides updated recommendations and practical guidance for the evaluation and management of GERD, including pharmacologic, lifestyle, surgical, and endoscopic management. The use of proton pump inhibitors (PPIs) has raised concerns about long-term safety and overprescribing. New data regarding surgical and endoscopic interventions have also emerged.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2022)

Article Medicine, General & Internal

Use of serotonin reuptake inhibitor antidepressants and the risk of bleeding complications in patients on anticoagulant or antiplatelet agents: a systematic review and meta-analysis

Surapon Nochaiwong et al.

Summary: This systematic review and meta-analysis found that the use of serotonin reuptake inhibitor (SRI) antidepressants in patients receiving antithrombotic therapy is associated with a higher risk of bleeding complications, including major bleeding, gastrointestinal bleeding, and any bleeding events. The risk is elevated among individuals receiving anticoagulants or antiplatelet therapy. Caution should be exercised in co-prescribing SRIs with antithrombotic therapy due to safety concerns regarding bleeding risks.

ANNALS OF MEDICINE (2022)

Review Gastroenterology & Hepatology

AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert Review

Rena Yadlapati et al.

Summary: This review outlines a personalized diagnostic and therapeutic approach to GERD symptoms and provides detailed recommendations for clinical practice.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review

Laura E. Targownik et al.

Summary: Proton pump inhibitors (PPIs) are widely used medications, but over prescription can lead to economic costs and adverse events. Deprescribing PPIs in ambulatory patients is an important strategy to reduce pill burden and costs. This clinical update provides best practice advice on PPI deprescribing.

GASTROENTEROLOGY (2022)

Article Gastroenterology & Hepatology

Baveno VII - Renewing consensus in portal hypertension

Roberto de Franchis et al.

Summary: The Baveno VII workshop focused on personalized care for portal hypertension in patients with compensated cirrhosis or cACLD, discussing various aspects including diagnosis, treatment, and prevention measures in 9 main topics, resulting in a series of consensus recommendations.

JOURNAL OF HEPATOLOGY (2022)

Review Gastroenterology & Hepatology

On-demand Versus Continuous Maintenance Treatment of Gastroesophageal Reflux Disease With Proton Pump Inhibitors: A Systematic Review and Meta-analysis

Seung Joo Kang et al.

Summary: On-demand PPI therapy shows comparable efficacy to continuous maintenance treatment in GERD patients. For non-erosive esophageal reflux disease and mild erosive reflux disease patients, on-demand therapy can remarkably reduce the amount of PPI use.

JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY (2022)

Article Gastroenterology & Hepatology

Inappropriateness of Proton Pump Inhibitors After Hospital Discharge Is Associated with Thirty-Day Hospital Readmission

John W. Blackett et al.

Summary: The study found that discharge on inappropriate PPIs was associated with 30-day hospital readmission compared to appropriate PPIs. This may not be due to the direct effects of PPIs, as all patients in the study received PPIs, but rather patients who receive inappropriate PPIs may have additional patient-specific factors that place them at increased risk for hospital readmission.

DIGESTIVE DISEASES AND SCIENCES (2022)

Article Nutrition & Dietetics

The effect of gastric acid suppression on probiotic colonization in a double blinded randomized clinical trial

Gulshan Singh et al.

Summary: This study found that the use of proton pump inhibitors (PPIs) can disrupt the gut microbiota, but probiotic intervention can mitigate these changes. Additionally, PPIs enhance the colonization of certain probiotic bacterial species. Therefore, combining PPIs with probiotics may be a beneficial strategy.

CLINICAL NUTRITION ESPEN (2022)

Article Pharmacology & Pharmacy

Proton Pump Inhibitors and the Risk of Community-Acquired Pneumonia: An Updated Meta-analysis

Xuejiao Xun et al.

Summary: The study found that the use of PPIs may increase the risk of CAP, especially with a duration of less than 30 days. PPI use increased the incidence of CAP in patients with stroke, but not significantly in patients with liver disease.

ANNALS OF PHARMACOTHERAPY (2022)

Article Pediatrics

Proton pump inhibitors are still overprescribed for hospitalized children

A. Arnoux et al.

Summary: The use of proton pump inhibitors has increased significantly in the past 20 years, but there are concerns about their side effects and long-term health consequences. This study found that prescriptions of proton pump inhibitors in hospitalized children often do not comply with current recommendations, highlighting the need for increased awareness among hospital pediatricians.

ARCHIVES DE PEDIATRIE (2022)

Article Cardiac & Cardiovascular Systems

Non-vitamin K antagonist oral anticoagulants, proton pump inhibitors and gastrointestinal bleeds

Joris Komen et al.

Summary: Concomitant treatment with a PPI in NOAC-treated patients with AF is associated with a reduced risk of severe UGIB, especially in elderly patients, patients with a high HAS-BLED score, or patients on concomitant antiplatelet therapy.

HEART (2022)

Article Public, Environmental & Occupational Health

Proton pump inhibitors may enhance the risk of citalopram- and escitalopram-associated sudden cardiac death among patients receiving hemodialysis

Magdalene M. Assimon et al.

Summary: Polypharmacy is common in hemodialysis population and the concurrent use of proton pump inhibitors (PPIs) with citalopram or escitalopram may increase the risk of sudden cardiac death (SCD) among these patients. This retrospective cohort study found that citalopram/escitalopram initiators using a PPI had the highest risk of SCD, followed by citalopram/escitalopram initiators not using a PPI. Sertraline initiators using a PPI had a similar risk of SCD compared to those not using a PPI. This suggests that existing PPI use may elevate the risk of SCD associated with citalopram or escitalopram initiation among hemodialysis patients.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2022)

Review Pharmacology & Pharmacy

A Narrative Review on Efficacy and Safety of Proton Pump Inhibitors in Children

Valeria Dipasquale et al.

Summary: This study provides a comprehensive overview of the mechanism of actions, use, and safety of proton pump inhibitors (PPIs) in infants and children. It highlights the increased risks of gastrointestinal and lower respiratory tract infections, bone fractures, and allergy associated with long-term use of PPIs in children.

FRONTIERS IN PHARMACOLOGY (2022)

Review Pharmacology & Pharmacy

Protective effect of proton-pump inhibitor against gastrointestinal bleeding in patients receiving oral anticoagulants: A systematic review and meta-analysis

Hyo-Jeong Ahn et al.

Summary: This meta-analysis found that proton-pump inhibitor (PPI) cotherapy in oral anticoagulant (OAC)-treated patients is associated with a lower risk of gastrointestinal bleeding (GIB). This protective effect is independent of ethnic group and OAC type, except for edoxaban. PPI cotherapy may be particularly beneficial for patients with high risk of GIB.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2022)

Review Medicine, General & Internal

Which ICU patients need stress ulcer prophylaxis?

Mariam Saeed et al.

Summary: Critically ill patients often receive stress ulcer prophylaxis, but this treatment may be associated with an increased risk of pneumonia and Clostridioides difficile infection.

CLEVELAND CLINIC JOURNAL OF MEDICINE (2022)

Article Microbiology

Proton Pump Inhibitor-Induced Gut Dysbiosis Increases Mortality Rates for Patients with Clostridioides difficile Infection

Cheng-Yu Lin et al.

Summary: This study found that daily use of proton pump inhibitors (PPIs) was the only avoidable risk factor for death in patients with CDI. With longer duration of PPI use, the mortality rate was higher in CDI patients. Decreased relative abundance of Prevotella copri and Ruminococcus gnavus, and increased relative abundance of Parabacteroides merdae and Clostridioides difficile, in line with daily PPI use duration, were significantly associated with the death of CDI patients.

MICROBIOLOGY SPECTRUM (2022)

Review Oncology

Proton Pump Inhibitors and Cancer Risk An Umbrella Review and Meta-analysis of Observational Studies

Man-Li Zhang et al.

Summary: The umbrella review found that the use of PPIs is associated with an increased risk of certain cancers, including gastric, pancreatic, colorectal, and liver cancer, but is not associated with esophageal cancer. Additionally, PPI use is associated with a decreased risk of breast cancer.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2022)

Article Gastroenterology & Hepatology

Endoscopic diagnosis and management of esophagogastric variceal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline

Ian M. Gralnek et al.

Summary: This article summarizes ESGE recommendations for the treatment of patients with chronic liver disease, including the prevention of variceal bleeding, management of acute upper gastrointestinal hemorrhage, and endoscopic therapy.

ENDOSCOPY (2022)

Article Gastroenterology & Hepatology

Asian-Pacific consensus on small intestinal bacterial overgrowth in gastrointestinal disorders: An initiative of the Indian Neurogastroenterology and Motility Association

Uday C. Ghoshal et al.

Summary: Small intestinal bacterial overgrowth (SIBO) is a common but often under-diagnosed condition in the clinical setting. In this study, experts from the Asian-Pacific region developed an evidence-based practice guideline for the management of SIBO using a modified Delphi process. The guideline provides consensus statements in different areas to guide clinical practice, teaching, and research on SIBO.

INDIAN JOURNAL OF GASTROENTEROLOGY (2022)

Article Gastroenterology & Hepatology

Does Chronic Use of High Dose Proton Pump Inhibitors Increase Risk for Pancreatic Cancer?

Matthew A. Huber et al.

Summary: The study found a correlation between the use of proton pump inhibitors and an increased risk for pancreatic cancer in both murine models and human subjects.

PANCREAS (2022)

Review Gastroenterology & Hepatology

Exploring Treatment Options for Eosinophilic Esophagitis

Nicole Strossman et al.

Summary: Eosinophilic esophagitis (EoE) is a chronic inflammatory disease of the esophagus. The main treatment options include dietary modifications, steroids, proton pump inhibitors (PPIs), and endoscopic dilation. Preliminary studies on new medications targeting inflammatory mediators show promise in improving symptoms.

GASTROENTEROLOGY INSIGHTS (2022)

Review Medicine, General & Internal

Evidence-based treatment recommendations for gastroesophageal reflux disease during pregnancy: A review

Mansour Altuwaijri

Summary: Gastroesophageal reflux disease (GERD) is common in pregnancy, affecting around two-thirds of all pregnancies. Treatment aims to alleviate symptoms without compromising the pregnancy or its outcome. A step-up approach to treatment is recommended, starting with lifestyle modifications and progressing to medication if necessary. Antacids and histamine-2 receptor antagonists are the preferred choice of medications.

MEDICINE (2022)

Article Pediatrics

Clinical Practice Guidelines on Pediatric Gastroesophageal Reflux Disease: A Systematic Quality Appraisal of International Guidelines

Jacob Harris et al.

Summary: While high-quality clinical practice guidelines (CPGs) pertaining to the diagnosis and treatment of pediatric GERD exist, many published guidelines lack methodological rigor and broad applicability.

PEDIATRIC GASTROENTEROLOGY HEPATOLOGY & NUTRITION (2022)

Review Infectious Diseases

The Use of Proton Pump Inhibitors and COVID-19: A Systematic Review and Meta-Analysis

Kaneez Fatima et al.

Summary: This meta-analysis study found that the use of proton pump inhibitors (PPI) is associated with an increased risk of COVID-19 infection, severity of illness, and mortality.

TROPICAL MEDICINE AND INFECTIOUS DISEASE (2022)

Review Gastroenterology & Hepatology

The Efficacy of Proton Pump Inhibitor in Cirrhotics with Variceal Bleeding: A Systemic Review and Meta-Analysis

Lin Lin et al.

Summary: The use of PPI for more than one month in cirrhotic patients can reduce the re-bleeding rate after endoscopic therapy, but it does not have an impact on bleeding-related mortality.

DIGESTION (2021)

Review Immunology

Acid Suppression Medications During Hospitalization as a Risk Factor for Recurrence of Clostridioides difficile Infection: Systematic Review and Meta-analysis

Palna Mehta et al.

Summary: A systematic review and meta-analysis found that the use of acid-suppression medications (ASMs) during hospitalization was associated with a higher risk of recurrent Clostridioides difficile infection (CDI), especially with proton pump inhibitor (PPI) use. Further studies are needed to clarify the iatrogenic effects of ASMs, and unnecessary PPI use should be discontinued.

CLINICAL INFECTIOUS DISEASES (2021)

Article Gastroenterology & Hepatology

The treatment efficacy of adding prokinetics to PPIs for gastroesophageal reflux disease: a meta-analysis

Liting Xi et al.

Summary: Adding prokinetics to PPIs can improve symptom response in GERD patients, but seems to have no significant effect on mucosal healing.

ESOPHAGUS (2021)

Article Gastroenterology & Hepatology

Management of Helicobacter pylori infection: The Bhubaneswar Consensus Report of the Indian Society of Gastroenterology

Shivaram Prasad Singh et al.

Summary: The Indian Society of Gastroenterology formed a Task Force on Helicobacter pylori to produce consensus statements on the infection. Twenty-five experts from various fields participated in the process, reviewing literature and developing statements through a modified Delphi process. The resulting consensus serves as a guide for the diagnosis and management of H. pylori infection and future research in the field.

INDIAN JOURNAL OF GASTROENTEROLOGY (2021)

Review Gastroenterology & Hepatology

Consensus for the management of pancreatic exocrine insufficiency: UK practical guidelines

Mary E. Phillips et al.

Summary: Pancreatic exocrine insufficiency affects patients with pancreatic diseases, impacting quality of life and survival. Practical management advice for healthcare professionals is needed, and consensus recommendations for diagnosis, education, and follow-up have been developed through expert panel consensus.

BMJ OPEN GASTROENTEROLOGY (2021)

Article Pharmacology & Pharmacy

Adverse outcomes of proton pump inhibitors in patients with chronic kidney disease: The CKD-REIN cohort study

Sophie Liabeuf et al.

Summary: Long-term use of proton pump inhibitors is common among chronic kidney disease patients, and it is associated with an increased risk of acute kidney injury, end-stage kidney disease, and all-cause mortality.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)

Review Medicine, General & Internal

Gastroprotection in patients on antiplatelet and/or anticoagulant therapy: a position paper of National Association of Hospital Cardiologists (ANMCO) and the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO)

Maurizio Giuseppe Abrignani et al.

Summary: The combination of antiplatelet drugs and PPIs is widely used in the treatment of cardiovascular and cerebrovascular diseases, but may increase the risk of cardiovascular events. The use of PPIs should be considered in patients taking anticoagulants with a risk of gastrointestinal bleeding.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2021)

Article Multidisciplinary Sciences

Drug use for gastrointestinal symptoms during pregnancy: A French nationwide study 2010-2018

Antoine Meyer et al.

Summary: A large proportion of pregnant women in France use gastrointestinal drugs during pregnancy, with antacids being the most commonly prescribed. The use of prescription drugs shows varying trends across different trimesters of pregnancy.

PLOS ONE (2021)

Article Pharmacology & Pharmacy

A New Score for Predicting Acute Gastrointestinal Bleeding in Patients Administered Oral Antiplatelet Drugs

Meina Lv et al.

Summary: An established score named (ABC)(2)D was developed to predict the risk of gastrointestinal bleeding, incorporating seven risk factors. The (ABC)(2)D score outperformed the CRUSADE score in predicting acute gastrointestinal bleeding risk. This new risk-scoring model may help identify patients at significant risk of gastrointestinal bleeding.

FRONTIERS IN PHARMACOLOGY (2021)

Article Gastroenterology & Hepatology

ACG Clinical Guideline: Upper Gastrointestinal and Ulcer Bleeding

Loren Laine et al.

Summary: Systematic reviews were conducted to develop recommendations for the management of patients with overt upper gastrointestinal bleeding, suggesting risk assessment and red blood cell transfusion based on hemoglobin levels. Endoscopic therapy is recommended for ulcers with active bleeding or nonbleeding visible vessels, with repeat endoscopy and transcatheter embolization options available if therapy fails.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)

Article Gastroenterology & Hepatology

2020 Seoul Consensus on the Diagnosis and Management of Gastroesophageal Reflux Disease

Hye-Kyung Jung et al.

Summary: GERD is a condition where gastric contents regurgitate into the esophagus, causing troublesome symptoms or complications. Diagnosis can be established through symptomatology, pathology, or physiology. Research is focusing on diagnostic standards and treatment methods for the Asian population.

JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY (2021)

Article Pharmacology & Pharmacy

Proton pump inhibitor on susceptibility to COVID-19 and its severity: a systematic review and meta-analysis

Raymond Pranata et al.

Summary: This meta-analysis revealed a potential association between PPI use and composite poor outcome, but not susceptibility to COVID-19.

PHARMACOLOGICAL REPORTS (2021)

Review Gastroenterology & Hepatology

Proton pump inhibitors use and risk of developing spontaneous bacterial peritonitis in cirrhotic patients: A systematic review and meta-analysis

Saad Alhumaid et al.

Summary: This meta-analysis highlights the conflicting results regarding the association between SBP and PPIs use, showing a weak yet statistically significant association between the two. However, the strength of the association diminished when focusing on higher quality data. Therefore, judicious use of PPIs among cirrhotic patients with ascites is recommended based on this updated meta-analysis.

GUT PATHOGENS (2021)

Letter Pediatrics

Inappropriate Prescribing of Proton Pump Inhibitors in Children: Insights from a Survey

Renu Yadav et al.

INDIAN JOURNAL OF PEDIATRICS (2021)

Article Urology & Nephrology

Proton-pump inhibitor vs. H2-receptor blocker use and overall risk of CKD progression

Liza Cholin et al.

Summary: The relationship between PPI use and CKD progression remains controversial, with a lack of data evaluating renal outcomes in established CKD patients. This study found that among CKD patients, PPI use was not associated with increased mortality or progression to ESKD when compared to H2 blocker and no acid suppressing therapy.

BMC NEPHROLOGY (2021)

Review Pharmacology & Pharmacy

Clinical Outcomes of Concomitant Use of Proton Pump Inhibitors and Dual Antiplatelet Therapy: A Systematic Review and Meta-Analysis

Hongzhou Guo et al.

Summary: The use of proton pump inhibitors (PPIs) in patients with coronary artery disease receiving dual antiplatelet therapy (DAPT) did not show a significant association with major adverse cardiovascular events, but was significantly associated with a reduced risk of gastrointestinal bleeding. Different PPI subtypes may have inconsistent effects on the development of myocardial infarction.

FRONTIERS IN PHARMACOLOGY (2021)

Article Gastroenterology & Hepatology

Effectiveness of PPI treatment and guideline adherence in 236 patients with eosinophilic oesophagitis-Results from the population-based DanEoE cohort shows a low complication rate

Line Tegtmeier Frandsen et al.

Summary: This study assessed the effectiveness of PPIs in treating EoE and evaluated whether patients were treated according to guidelines. Results showed that high-dose PPI treatment was effective in half of EoE patients, but conflicting symptomatic and histological responses were common. Complications were rare when PPIs were started, and one-third of patients were not rebiopsied as recommended.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2021)

Article Gastroenterology & Hepatology

Potentially inappropriate proton-pump inhibitor prescription in the general population: a claims-based retrospective time trend analysis

Leander Muheim et al.

Summary: This study revealed an increasing trend of inappropriate use of proton-pump inhibitors in the general population, with multimorbidity and drugs with bleeding risks identified as strong determinants of inappropriate use. Addressing prescriptions exceeding guideline recommendations could potentially reduce polypharmacy and enhance patient safety.

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2021)

Article Gastroenterology & Hepatology

Prevalence and risk factors for gastroesophageal reflux disease in the Indian population: A meta-analysis and meta-regression study

Sushmita Rai et al.

Summary: There is a lack of Indian population-based studies on the prevalence and risk factors for gastroesophageal reflux disease (GERD), with no reported meta-analysis and meta-regression based on existing data. A systematic review of Indian publications on GERD was conducted. The pooled prevalence of GERD in the Indian population was found to be 15.6%, with age, BMI, non-vegetarian diet, tea/coffee intake, tobacco, and alcohol consumption as risk factors, although there was significant heterogeneity in the studies.

INDIAN JOURNAL OF GASTROENTEROLOGY (2021)

Review Gastroenterology & Hepatology

Phenotypes of Gastroesophageal Reflux Disease: Where Rome, Lyon, and Montreal Meet

David A. Katzka et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)

Review Gastroenterology & Hepatology

No association between proton pump inhibitor use and risk of dementia: Evidence from a meta-analysis

Salman Hussain et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2020)

Article Endocrinology & Metabolism

Proton pump inhibitors and fracture risk. The HUNT study, Norway

M. Hoff et al.

OSTEOPOROSIS INTERNATIONAL (2020)

Review Gastroenterology & Hepatology

Systematic review with meta-analysis: the risks of proton pump inhibitors during pregnancy

Cheng Mei Li et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)

Article Gastroenterology & Hepatology

ACG Clinical Guideline: Chronic Pancreatitis

Timothy B. Gardner et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)

Review Gastroenterology & Hepatology

No Association Linking Short-Term Proton Pump Inhibitor Use to Dementia: Systematic Review and Meta-analysis of Observational Studies

Muhammad Ali Khan et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)

Review Gastroenterology & Hepatology

AGA Clinical Practice Update on Functional Heartburn: Expert Review

Ronnie Fass et al.

GASTROENTEROLOGY (2020)

Review Gastroenterology & Hepatology

Adverse outcomes of proton pump inhibitors in chronic liver disease: a systematic review and meta-analysis

Junna Wang et al.

HEPATOLOGY INTERNATIONAL (2020)

Article Pediatrics

Natural history of gastroesophageal reflux in infancy: new data from a prospective cohort

Marlene Curien-Chotard et al.

BMC PEDIATRICS (2020)

Review Gastroenterology & Hepatology

Clinical Practice Guidelines for Functional Dyspepsia in Korea

Jung Hwan Oh et al.

JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY (2020)

Editorial Material Gastroenterology & Hepatology

Proton pump inhibitors in chronic liver disease: accomplice or bystander?

Lung-Yi Mak et al.

HEPATOLOGY INTERNATIONAL (2020)

Review Health Care Sciences & Services

Meta-analysis of proton pump inhibitors induced risk of community-acquired pneumonia

Phung Anh Nguyen et al.

INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE (2020)

Article Gastroenterology & Hepatology

Efficacy of proton pump inhibitor therapy for eosinophilic oesophagitis in 630 patients: results from the EoE connect registry

Emilio J. Laserna-Mendieta et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)

Letter Gastroenterology & Hepatology

Letter: safety of proton pump inhibitors during pregnancy

Selin Acar et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)

Letter Gastroenterology & Hepatology

Letter: safety of proton pump inhibitors during pregnancy-authors' reply

Cheng Mei Li et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)

Review Gastroenterology & Hepatology

Management of regurgitation in patients with gastroesophageal reflux disease

Reginald C. W. Bell

CURRENT OPINION IN GASTROENTEROLOGY (2020)

Review Medicine, General & Internal

Functional Gastrointestinal Disorders 3 Functional dyspepsia

Alexander C. Ford et al.

LANCET (2020)

Review Public, Environmental & Occupational Health

Risk factors for Clostridium difficile infection in pediatric inpatients: A meta-analysis and systematic review

Scott Anjewierden et al.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2019)

Article Medicine, Research & Experimental

Proton pump inhibitors therapy and risk of bone diseases: An update meta-analysis

Jian Liu et al.

LIFE SCIENCES (2019)

Article Public, Environmental & Occupational Health

Proton-pump inhibitors and the risk of Clostridium difficile-associated diarrhea in high-risk antibiotics users: A population-based case-crossover study

Sung-Hyun Hong et al.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2019)

Article Medicine, General & Internal

Proton pump inhibitor use and progression to major adverse renal events: a competing risk analysis

C. H. Grant et al.

QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2019)

Article Gastroenterology & Hepatology

Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis

Marianne Anastasia De Roza et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2019)

Review Medicine, General & Internal

Proton pump inhibitors and hypomagnesemia A meta-analysis of observational studies

Thawin Srinutta et al.

MEDICINE (2019)

Article Medicine, General & Internal

Risk factors for upper gastrointestinal bleeding among aspirin users: An old issue with new findings from a population-based cohort study

Pei-Jui Luo et al.

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2019)

Article Endocrinology & Metabolism

Proton pump inhibitors and risk of hip fracture: a meta-analysis of observational studies

T. N. Poly et al.

OSTEOPOROSIS INTERNATIONAL (2019)

Article Surgery

Laryngopharyngeal Reflux and GERD: Correlation Between Reflux Symptom Index and Reflux Finding Score

C. Shilpa et al.

INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY (2019)

Article Gastroenterology & Hepatology

Prevalence and factors associated with gastroesophageal reflux disease in southern India: A community-based study

Sudipta Dhar Chowdhury et al.

INDIAN JOURNAL OF GASTROENTEROLOGY (2019)

Article Gastroenterology & Hepatology

Indian consensus on gastroesophageal reflux disease in adults: A position statement of the Indian Society of Gastroenterology

Shobna J. Bhatia et al.

INDIAN JOURNAL OF GASTROENTEROLOGY (2019)

Article Gastroenterology & Hepatology

Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis

Leonardo H. Eusebi et al.

Article Pharmacology & Pharmacy

Gastrointestinal bleeding risk of selective serotonin reuptake inhibitors by level of kidney function: A population-based cohort study

Masao Iwagami et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)

Article Pharmacology & Pharmacy

Safe use of proton pump inhibitors in patients with cirrhosis

Rianne A. Weersink et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)

Review Gastroenterology & Hepatology

Interchangeable Use of Proton Pump Inhibitors Based on Relative Potency

David Y. Graham et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)

Article Gastroenterology & Hepatology

Management of Gastroesophageal Reflux Disease

C. Prakash Gyawali et al.

GASTROENTEROLOGY (2018)

Article Gastroenterology & Hepatology

Modern diagnosis of GERD: the Lyon Consensus

C. Prakash Gyawali et al.

Review Public, Environmental & Occupational Health

Updated meta-analysis of controlled observational studies: proton-pump inhibitors and risk of Clostridium difficile infection

F. Cao et al.

JOURNAL OF HOSPITAL INFECTION (2018)

Article Gastroenterology & Hepatology

Is It Useful to Administer Probiotics Together With Proton Pump Inhibitors in Children With Gastroesophageal Reflux?

Oana Belei et al.

JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY (2018)

Article Gastroenterology & Hepatology

A Simple Pre-endoscopy Score for Predicting Risk of Malignancy in Patients with Dyspepsia: A 5-Year Prospective Study

Amit Kumar Dutta et al.

DIGESTIVE DISEASES AND SCIENCES (2018)

Article Medicine, General & Internal

Pantoprazole in Patients at Risk for Gastrointestinal Bleeding in the ICU

M. Krag et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Review Gastroenterology & Hepatology

Systematic review: human gut dysbiosis induced by non-antibiotic prescription medications

Q. Le Bastard et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)

Article Gastroenterology & Hepatology

Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report

P. Malfertheiner et al.

Review Pharmacology & Pharmacy

Risk of gastrointestinal bleeding during anticoagulant treatment

Aitor Lanas-Gimeno et al.

EXPERT OPINION ON DRUG SAFETY (2017)

Review Gastroenterology & Hepatology

25 Years of Proton Pump Inhibitors: A Comprehensive Review

Daniel S. Strand et al.

GUT AND LIVER (2017)

Article Gastroenterology & Hepatology

Study of Gender Differences in Proton Pump Inhibitor Dose Requirements for GERD A Double-Blind Randomized Trial

Holmfridur Helgadottir et al.

JOURNAL OF CLINICAL GASTROENTEROLOGY (2017)

Review Gastroenterology & Hepatology

Proton-pump inhibitors: understanding the complications and risks

Peter Malfertheiner et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)

Article Chemistry, Medicinal

Proton-pump inhibitors use, and risk of acute kidney injury: a meta-analysis of observational studies

Yi Yang et al.

DRUG DESIGN DEVELOPMENT AND THERAPY (2017)

Article Medicine, General & Internal

Functional dyspepsia

Paul Enck et al.

NATURE REVIEWS DISEASE PRIMERS (2017)

Article Multidisciplinary Sciences

Effectiveness of proton pump inhibitor in unexplained chronic cough

Hye Jung Park et al.

PLOS ONE (2017)

Review Gastroenterology & Hepatology

Risk of Gastrointestinal Bleeding in Patients Taking Non-Vitamin K Antagonist Oral Anticoagulants: A Systematic Review and Meta-analysis

Corey S. Miller et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)

Review Gastroenterology & Hepatology

ACG and CAG Clinical Guideline: Management of Dyspepsia

Paul M. Moayyedi et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)

Article Surgery

Assessment of treatment response in patients with laryngopharyngeal reflux

Anagha Atul Joshi et al.

INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY (2017)

Article Gastroenterology & Hepatology

The efficacy of step-down therapy in adult patients with proton pump inhibitor-responsive oesophageal eosinophilia

E. Gomez-Torrijos et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)

Article Geriatrics & Gerontology

Inappropriate use of proton pump inhibitors in elderly patients discharged from acute care hospitals

R. Schepisi et al.

JOURNAL OF NUTRITION HEALTH & AGING (2016)

Article Endocrinology & Metabolism

Proton-pump inhibitors and risk of fractures: an update meta-analysis

B. Zhou et al.

OSTEOPOROSIS INTERNATIONAL (2016)

Correction Gastroenterology & Hepatology

ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus (vol 111, pg 30, 2016)

Nicholas J. Shaheen et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)

Article Gastroenterology & Hepatology

The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults

Carlo A. Fallone et al.

GASTROENTEROLOGY (2016)

Article Gastroenterology & Hepatology

Proton Pump Inhibitor Therapy for the Treatment of Laryngopharyngeal Reflux A Meta-Analysis of Randomized Controlled Trials

Huaiyuan Guo et al.

JOURNAL OF CLINICAL GASTROENTEROLOGY (2016)

Article Gastroenterology & Hepatology

High Prevalence of Response to Proton-pump Inhibitor Treatment in Children With Esophageal Eosinophilia

Carolina Gutierrez-Junquera et al.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2016)

Editorial Material Urology & Nephrology

Proton Pump Inhibitors and CKD

Dennis G. Moledina et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)

Article Gastroenterology & Hepatology

Use of Selective Serotonin Reuptake Inhibitors and Risk of Upper Gastrointestinal Bleeding: A Systematic Review and Meta-analysis

Hai-Yin Jiang et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)

Review Gastroenterology & Hepatology

Systematic review and meta-analysis of the possible association between pharmacological gastric acid suppression and spontaneous bacterial peritonitis

Muhammad Ali Khan et al.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2015)

Article Gastroenterology & Hepatology

Esomeprazole for the Treatment of Erosive Esophagitis in Children: An International, Multicenter, Randomized, Parallel-Group, Double-Blind (for Dose) Study

Vasundhara Tolia et al.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2015)

Review Medicine, General & Internal

Functional Dyspepsia

Nicholas J. Talley et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Review Gastroenterology & Hepatology

Epidemiology of Functional Gastrointestinal Disorders in Japan and in the World

Tadayuki Oshima et al.

JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY (2015)

Article Gastroenterology & Hepatology

Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis

Alexander C. Ford et al.

Article Gastroenterology & Hepatology

Maintenance of Efficacy and Safety of Rabeprazole in Children With Endoscopically Proven GERD

Ibrahim Haddad et al.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2014)

Review Urology & Nephrology

Acute kidney injury-epidemiology, outcomes and economics

Oleksa Rewa et al.

NATURE REVIEWS NEPHROLOGY (2014)

Article Gastroenterology & Hepatology

Addition of prokinetics to PPI therapy in gastroesophageal reflux disease: A meta-analysis

Li-Hua Ren et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Review Biochemistry & Molecular Biology

Vitamin B12 absorption: Mammalian physiology and acquired and inherited disorders

Renata Kozyraki et al.

BIOCHIMIE (2013)

Review Gastroenterology & Hepatology

Proton Pump Inhibitor Use and the Risk of Small Intestinal Bacterial Overgrowth: A Meta-analysis

Wai-Kit Lo et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)

Article Critical Care Medicine

Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012

R. P. Dellinger et al.

INTENSIVE CARE MEDICINE (2013)

Article Endocrinology & Metabolism

The effects of risedronate administered in combination with a proton pump inhibitor for the treatment of osteoporosis

Soichiro Itoh et al.

JOURNAL OF BONE AND MINERAL METABOLISM (2013)

Article Gastroenterology & Hepatology

Acid-suppressive therapy is associated with spontaneous bacterial peritonitis in cirrhotic patients: A meta-analysis

Abhishek Deshpande et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)

Article Gastroenterology & Hepatology

Efficacy and Safety of Rabeprazole in Children (1-11 Years) With Gastroesophageal Reflux Disease

Ibrahim Haddad et al.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2013)

Article Medicine, General & Internal

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

Robert P. Giugliano et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Multidisciplinary Sciences

Proton Pump Inhibitor Use in the US Ambulatory Setting, 2002-2009

Stephen R. Rotman et al.

PLOS ONE (2013)

Article Gastroenterology & Hepatology

Proton pump inhibitor for non-erosive reflux disease: A meta-analysis

Ji-Xiang Zhang et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2013)

Article Gastroenterology & Hepatology

Meta-analysis: esomeprazole or rabeprazole vs. first-generation pump inhibitors in the treatment of Helicobacter pylori infection

A. G. McNicholl et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)

Article Gastroenterology & Hepatology

Regurgitation Is Less Responsive to Acid Suppression Than Heartburn in Patients With Gastroesophageal Reflux Disease

Peter J. Kahrilas et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)

Article Gastroenterology & Hepatology

The Safety of Fetal Exposure to Proton-Pump Inhibitors During Pregnancy

I. Matok et al.

DIGESTIVE DISEASES AND SCIENCES (2012)

Article Gastroenterology & Hepatology

Noncardiac chest pain: diagnostic evaluation

R. Fass et al.

DISEASES OF THE ESOPHAGUS (2012)

Article Gastroenterology & Hepatology

How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related?

Nicola de Bortoli et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2012)

Article Medicine, General & Internal

Apixaban versus Warfarin in Patients with Atrial Fibrillation

Christopher B. Granger et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Medicine, General & Internal

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

Manesh R. Patel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Multidisciplinary Sciences

Selective Serotonin Reuptake Inhibitors and Gastrointestinal Bleeding: A Case-Control Study

Alfonso Carvajal et al.

PLOS ONE (2011)

Review Pharmacology & Pharmacy

Update on the pharmacogenomics of proton pump inhibitors

Krisztina Hagymasi et al.

PHARMACOGENOMICS (2011)

Article Gastroenterology & Hepatology

Healing of Erosive Esophagitis and Improvement of Symptoms of Gastroesophageal Reflux Disease After Esomeprazole Treatment in Children 12 to 36 Months Old

Vasundhara Tolia et al.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2010)

Article Gastroenterology & Hepatology

Predictive factors of bleeding related to post-banding ulcer following endoscopic variceal ligation in cirrhotic patients: a case-control study

G. Vanbiervliet et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)

Article Medicine, General & Internal

Outcomes With Concurrent Use of Clopidogrel and Proton-Pump Inhibitors A Cohort Study

Wayne A. Ray et al.

ANNALS OF INTERNAL MEDICINE (2010)

Review Critical Care Medicine

Stress ulcer prophylaxis in the new millennium: A systematic review and meta-analysis

Paul E. Marik et al.

CRITICAL CARE MEDICINE (2010)

Article Medicine, General & Internal

Use of Proton-Pump Inhibitors in Early Pregnancy and the Risk of Birth Defects.

Bjorn Pasternak et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Gastroenterology & Hepatology

PPIs are not associated with a lower incidence of portal-hypertension-related bleeding in cirrhosis

Mauricio Garcia-Saenz-de-Sicilia et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2010)

Article Gastroenterology & Hepatology

Therapeutic intent of proton pump inhibitor prescription among elderly nonsteroidal anti-inflammatory drug users

A. M. Dries et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)

Review Gastroenterology & Hepatology

The Safety of Proton Pump Inhibitors (PPIs) in Pregnancy: A Meta-Analysis

Simerpal K. Gill et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)

Review Gastroenterology & Hepatology

American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2008

Douglas K. Rex et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)

Article Cardiac & Cardiovascular Systems

Gastrointestinal bleeding in high risk survivors of myocardial infarction: the VALIANT Trial

George V. Moukarbel et al.

EUROPEAN HEART JOURNAL (2009)

Article Gastroenterology & Hepatology

Comparison of one-week and two-week empirical trial with a high-dose rabeprazole in non-cardiac chest pain patients

Jeong Hwan Kim et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)

Article Medicine, General & Internal

Dabigatran versus Warfarin in Patients with Atrial Fibrillation.

Stuart J. Connolly et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Article Medicine, General & Internal

Efficacy of Esomeprazole for Treatment of Poorly Controlled Asthma

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Article Gastroenterology & Hepatology

Management and outcome of peptic ulcers or erosions in patients receiving a combination of aspirin plus clopidogrel

Fook Hong Ng et al.

JOURNAL OF GASTROENTEROLOGY (2008)

Article Cardiac & Cardiovascular Systems

2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention

Spencer B. King et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)

Article Gastroenterology & Hepatology

The association between gastro-oesophageal reflux disease and asthma: a systematic review

B. D. Havemann et al.

Review Gastroenterology & Hepatology

Systematic review: proton pump inhibitor-associated acute interstitial nephritis

F. Sierra et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)

Review Gastroenterology & Hepatology

Systematic review: maintenance treatment of gastro-oesophageal reflux disease with proton pump inhibitors taken 'on-demand'

F. Pace et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)

Article Urology & Nephrology

Community-based incidence of acute renal failure

C-y Hsu et al.

KIDNEY INTERNATIONAL (2007)

Review Gastroenterology & Hepatology

Systematic review of the risk of enteric infection in patients taking acid suppression

Jennifer Leonard et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)

Article Gastroenterology & Hepatology

Esomeprazole versus other proton pump inhibitors in erosive esophagitis: A meta-analysis of randomized clinical trials

Ian M. Gralnek et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)

Article Gastroenterology & Hepatology

Discontinuation of proton pump inhibitors in patients on long-term therapy:: a double-blind, placebo-controlled trial

E. Bjornsson et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)

Article Gastroenterology & Hepatology

Randomized active and placebo-controlled endoscopy study of a novel protected formulation of oral alendronate

John K. Marshall et al.

DIGESTIVE DISEASES AND SCIENCES (2006)

Article Gastroenterology & Hepatology

Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors

JM Scheiman et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)

Review Medicine, General & Internal

Selective serotonin reuptake inhibitors and risk of upper GI bleeding: Confusion or confounding?

Yuhong Yuan et al.

AMERICAN JOURNAL OF MEDICINE (2006)

Article Medicine, General & Internal

Effects of proton pump inhibitors on calcium carbonate absorption in women: A randomized crossover trial

MB O'Connell et al.

AMERICAN JOURNAL OF MEDICINE (2005)

Article Gastroenterology & Hepatology

Diagnostic and therapeutic use of proton pump inhibitors in non-cardiac chest pain: A metaanalysis

F Cremonini et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)

Review Pharmacology & Pharmacy

Pharmacokinetics of proton pump inhibitors in children

C Litalien et al.

CLINICAL PHARMACOKINETICS (2005)

Article Gastroenterology & Hepatology

Gastroesophageal reflux disease in noncardiac chest pain

EM Faybush et al.

GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2004)

Article Medicine, General & Internal

Effect of omeprazole on oral iron replacement in patients with iron deficiency anemia

VR Sharma et al.

SOUTHERN MEDICAL JOURNAL (2004)

Article Gastroenterology & Hepatology

Helicobacter pylori eradication is beneficial in the treatment of functional dyspepsia

P Malfertheiner et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)

Article Gastroenterology & Hepatology

Short- and long-term therapy for reflux oesophagitis in the elderly: a multi-centre, placebo-controlled study with pantoprazole

A Pilotto et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)

Review Biotechnology & Applied Microbiology

A proton-pump inhibitor expedition: The case histories of omeprazole and esomeprazole

L Olbe et al.

NATURE REVIEWS DRUG DISCOVERY (2003)

Article Audiology & Speech-Language Pathology

The prevalence of hypopharynx findings associated with gastroesophageal reflux in normal volunteers

DM Hicks et al.

JOURNAL OF VOICE (2002)

Article Medicine, General & Internal

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis.

C Bombardier et al.

NEW ENGLAND JOURNAL OF MEDICINE (2000)